nomacopan (rVA576)

DRUG2 trials

Sponsors

AKARI Therapeutics

Conditions

Bullous PemphigoidThrombotic Microangiopathies

Phase 3

Nomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy

TerminatedNCT04784455

AKARI TherapeuticsThrombotic Microangiopathies

Start: 2021-02-01End: 2024-05-15Updated: 2025-06-05

Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP)

WithdrawnNCT05061771

AKARI TherapeuticsBullous Pemphigoid

Start: 2022-05-06End: 2022-08-01Updated: 2025-04-09

Related Papers

Clinical severity classes in COVID-19 pneumonia have distinct immunological profiles, facilitating risk stratification by machine learning

Frontiers in Immunology2023-09-054 citations